Difference between revisions of "Part:BBa K209400"
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K209400 short</partinfo> | <partinfo>BBa_K209400 short</partinfo> | ||
Line 5: | Line 4: | ||
hM4 DREADD flanked by AarI BC sites. | hM4 DREADD flanked by AarI BC sites. | ||
− | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | This is an engineered version of the M4 muscarinic receptor that can be activated by the otherwise inert small molecule, clozapine-N-oxide. | ||
+ | |||
+ | Reference: | ||
+ | Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Armbruster BN, Li X, Pausch MH, Herlitze S, Roth BL. Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5163-8. Epub 2007 Mar 2. | ||
<!-- --> | <!-- --> |
Revision as of 20:25, 21 October 2009
AarI B-C part, hM4D
hM4 DREADD flanked by AarI BC sites.
Usage and Biology
This is an engineered version of the M4 muscarinic receptor that can be activated by the otherwise inert small molecule, clozapine-N-oxide.
Reference: Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Armbruster BN, Li X, Pausch MH, Herlitze S, Roth BL. Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5163-8. Epub 2007 Mar 2.
Sequence and Features
Assembly Compatibility:
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 184
Illegal PstI site found at 979 - 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 1215
Illegal PstI site found at 184
Illegal PstI site found at 979 - 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 184
Illegal PstI site found at 979 - 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 184
Illegal PstI site found at 979
Illegal NgoMIV site found at 1086 - 1000COMPATIBLE WITH RFC[1000]